Fresenius Kabi Usa, Llc: Xylocaine (lidocaine Hcl Injection, Usp), 1%, 200 Mg Per
Fresenius Kabi is recalling Xylocaine (lidocaine) injectable anesthetic in 20 mL vials because hair was found in some units. The recall affects products distributed nationwide across all U.S. states and territories. This is a Class II recall, meaning use of the affected product could cause serious adverse health consequences or death.
- Recalling firm
- Fresenius Kabi USA, LLC
- Product
- Xylocaine (lidocaine HCl Injection, USP), 1%, 200 mg per 20 mL (10 mg per mL), 25 Multiple-Dose Vials, 20 mL, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-485-27; NDC Vial: 63323-485-01
- Reason
- Presence of Particulate Matter: Hair was found in products
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-07-16
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide within in the USA
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/0dc0cad0-816a-4455-931c-581767b8959e